Search Results for "Specialty%20Drugs"

Drug prices in the United States are some of the highest in the world, which has triggered several policy proposals aimed at adopting pricing strategies used by other countries.

Not all approaches are suited to meeting policy makers and health plans’ goals of managing specialty drugs based on their value. Researchers conducted a qualitative study with Blue Cross Blue Shield plans interested in implementing value-based specialty pharmacy management to observe the plans’ objectives, strategies, and factors influencing their ability to execute on these strategies.

Research Data Analyst, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

The Drug Pricing Lab takes issue with The New York Times "Fact Check" on the recent Trump Administration proposal to pilot alternative reimbursement for Part B drugs.

Pharmaceutical manufacturers push for adoption of outcomes-based contracting as a means of achieving a value-based price, but such contracts are ill-suited to do so.

Three policy papers released by Health Affairs in collaboration with the Drug Pricing Lab and the Commonwealth Fund cover fundamental prescription drug pricing problems.

What happens when a patient uses a copay coupon?

The way Medicare Part D's benefit design shows that rebates actually increase patients' out-of-pocket costs while shifting spending from plan sponsors and manufacturers to Medicare.

Insurance companies now target specialty drugs.

What are unique features of the market for anticancer drugs?

News this week that Turing Pharmaceuticals raised the price of its 62-year-old Daraprim treatment by over 5,000% has brought drug prices back into the headlines.

Drug prices have taken center stage since Turing Pharmaceuticals raised the price of its off-patent parasite-fighting drug Daraprim by over 5,000%, but the issue has been lingering for far longer than Turing has even existed.

The United States spends some of the lowest amounts of its total healthcare on prescription drugs relative to other developed nations. But Americans also pay some of the highest prices for those drugs, relative to the rest of the world.